Phibro Animal Health | PAHC - Umsatzerlöse





Der Umsatz Veränderung Datum
Align Technology USD 1.06B 20M 2026-06
ANI Pharmaceuticals USD 266M 28.5M 2026-06
Aurora Cannabis CAD 38.01M 56.18M 2026-03
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Canopy Growth CAD 71.25M 3.29M 2026-03
Corcept Therapeutics USD 256.15M 91.25M 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Henry Schein USD 3.46B 90M 2026-06
Idexx Laboratories USD 1.22B 80M 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Merck USD 16.6B 310M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Pacira USD 192.4M 15.4M 2026-06
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 265.71M 15.91M 2026-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
Zoetis USD 2.5B 200M 2026-06